Gilead Sciences, Inc.  (Public, NASDAQ:GILD)

Gilead Sciences Extends Expiration Date for Tender Offer for Myogen 
Until November 13, 2006 
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: 
GILD) today announced that it has extended the initial expiration 
date for its previously announced tender offer for all of the 
outstanding shares of common stock of Myogen, Inc. (Nasdaq: MYOG) to 
Monday, November 13, 2006 at one minute following 11:59 p.m. New 
York City time (midnight). The originally announced expiration date 
for the tender offer, Friday, November 10, 2006, is a federal 
employee holiday. Therefore, the initial expiration date for the 
tender offer is being corrected and extended in order to ensure that 
the tender offer will remain open for the full minimum twenty 
business-day period required under Rule 14e-1 of the Securities 
Exchange Act of 1934, as amended. 

As of October 31, 2006, approximately 265,685 shares of Myogen 
common stock had been tendered and not withdrawn from the offer. The 
tender offer is expected to close by the end of the fourth quarter 
of 2006, subject to customary closing conditions. 

About Gilead Sciences 

Gilead Sciences is a biopharmaceutical company that discovers, 
develops and commercializes innovative therapeutics in areas of 
unmet medical need. The company's mission is to advance the care of 
patients suffering from life-threatening diseases worldwide. 
Headquartered in Foster City, California, Gilead has operations in 
North America, Europe and Australia. For more information on Gilead 
Sciences, please visit the company's website at www.gilead.com or 
call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. 

http://groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://famouspeople.wordpress.com/





http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
 
Yahoo! Groups Links

<*> To visit your group on the web, go to:
    http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
    Individual Email | Traditional

<*> To change settings online go to:
    http://groups.yahoo.com/group/biotech-news/join
    (Yahoo! ID required)

<*> To change settings via email:
    mailto:[EMAIL PROTECTED] 
    mailto:[EMAIL PROTECTED]

<*> To unsubscribe from this group, send an email to:
    [EMAIL PROTECTED]

<*> Your use of Yahoo! Groups is subject to:
    http://docs.yahoo.com/info/terms/
 

Reply via email to